Why BGPT?
logo

Review Papers Claim by Claim

Check each claim against its experiments, reported results, scope, and stated limitations.Know what the science actually supports before you trust the answer.

Press Enter ↡ to start review


     Quick Explanation



    Paper reviewed: Zuo et al., β€œWhole-exome SNP array identifies 15 new susceptibility loci for psoriasis” (Nat. Commun., 2015).
    Bottom line (skeptical): The paper is strongest as statistical genetics mapping (multi-stage design + replication), but causal biology remains mostly hypothesis-level because functional validation per variant is limited in what was provided.



     Long Explanation



    Whole-exome SNP array maps coding risk for psoriasis (Zuo et al., 2015)

    Three-stage, Han-Chinese whole-exome array analysis reports 15 new susceptibility loci/genes (via 16 SNPs) plus replication of 4 known loci, and claims an aggregate explained heritability fraction.

    Quick extraction from the provided text
    • Design / cohort: 3-stage case-control; 17,614 cases and 25,216 controls, self-reported Han Chinese.
    • Genotyping: custom Illumina Human Exome Asian BeadChip + Illumina Human Exome Fine Mapping BeadChip.
    • Outcome: 15 new genes/loci with 16 associated SNPs; replication of TNIP1, NFKBIA, IL12B, LCE3D-LCE3E.
    • Heritability fraction claim: discovered variants collectively account for 1.9% of psoriasis heritability (restricted maximum-likelihood method).

    Figure 1: Reported discovery SNP signals (from provided extracted list)

    Only SNPs explicitly present in the provided extracted list are plotted (to avoid inventing data). Significance shown as βˆ’log10(P) and effect size as OR.

    Figure 2: Directionality check (OR < 1 vs OR β‰₯ 1)

    Figure interpretation (skeptical): In the provided subset, more loci show OR < 1 (protective relative to the reference allele) than OR β‰₯ 1, but this is a subset visualization, not the full set of 15 loci. The paper’s biological claims require variant-level functional follow-up beyond association statistics.

    Mechanistic hypotheses the paper proposes (and what is actually supported)

    Coding variants & suggested biological pathways

    • MTHFR (rs2274976): Paper states MTHFR is a co-substrate in homocysteine methylation to methionine, supporting DNA methylation methyl donor availability and gene regulation/differentiation.
    • AIM2 (rs2276405): Paper describes AIM2 as a cytosolic dsDNA receptor forming an inflammasome (via apoptosis speck-like protein) that activates caspase-1 and influences tumorigenic reversion/cell proliferation; it also reports a protein-structure region and a predicted side-chain change (Gluβ†’Lys) that may destabilize an alpha-helix motif.
    • IL1RL1 (rs1420101): Paper places the variant in intron 3 and frames IL1RL1 as part of the interleukin-1 receptor family involved in helper T cell function and inducibility by proinflammatory stimuli.
    • IFNGR2 / Th17 axis claim: Paper states IFNGR2 encodes the non-ligand-binding beta chain of the gamma interferon receptor and may affect generation of Th17 cells from memory T cells.
    • Protein network enrichment: Paper reports that some newly identified non-HLA genes (MTHFR, NPPA, AIM2, CASR, IFNGR2) are significantly enriched in an interaction network (FDR<0.1).

    What is well-supported vs what is uncertain

    • Well-supported (within the scope of what is provided): genotype QC, PCA-based stratification control, and three-stage association with replication plus conditional/LD assessment are presented as key strengths.
    • Uncertain / needs more validation: biological mechanism claims primarily rely on (i) gene/protein function knowledge and (ii) in-silico predictions; the paper itself indicates additional study is needed to fully understand how variants contribute to pathogenesis.

    Statistical genetics critique (skeptical but fair)

    Major strengths

    • Large multi-stage design: discovery uses two exome-chip stages and then replication with an independent cohort and platform (Sequenom MassARRAY), aiming to reduce false positives.
    • Conditional/LD reasoning: the paper reports conditional analyses to show some loci are not secondary signals at known loci in the Chinese population.
    • Data availability claim: variant data are said to be deposited in dbVar (accession SUB822238).

    Key limitations & potential blind spots

    • Population generalizability: all samples are self-reported Han Chinese. Effect sizes and which variants are tagged by array probes can differ across ancestries due to LD structure.
    • Exome-chip coverage constraints: β€œwhole-exome SNP array” is still not equivalent to full sequencing. Thus some causal variants might be untyped or poorly tagged, and multiple testing burden is handled statistically but causality remains uncertain.
    • Heritability fraction is modest: the paper reports 1.9% of variance explained by the identified variants; by itself this does not β€œclose” the missing heritability problem and suggests much genetic architecture remains undiscovered or unexplained.
    • Mechanistic evidence is largely correlative/inferred: variant-to-function mapping uses in-silico damaging predictions (e.g., SIFT) and limited structural inspection (AIM2) rather than per-variant experimental functional assays in the provided content.
    • Phenotype measurement uncertainty: diagnosis is reported as made by dermatologists and controls are screened, but phenotype variability (e.g., disease severity, treatment history) can still add noise to association signals. The provided text does not quantify such covariates in detail.

    What evidence could disprove or revise this paper’s main claims?

    • Replication failure: independent cohorts (especially non-Han ancestries) showing no association at the claimed β€œnew” loci would weaken or falsify the locus discovery claims.
    • LD/causality re-mapping: fine-mapping or sequencing that identifies different causal variants within the same loci would change β€œwhich variant is causal,” even if association remains.
    • Functional contradiction: experimental assays showing that the specific coding/intronic variants have no functional impact on relevant pathways would undermine mechanistic plausibility.

    Table: Key reported results (only what is explicit in the provided text)

    Gene/Locus SNP (rsID) P-value Odds Ratio (OR) Direction note
    MTHFRrs22749762.33Γ—10^-100.79Protective vs reference allele
    IL1RL1rs14201011.71Γ—10^-100.88Protective vs reference allele
    ZNF143rs107431081.70Γ—10^-81.14Risk vs reference allele
    ZNF683rs107945324.18Γ—10^-81.11Risk vs reference allele
    TMC6rs124498582.28Γ—10^-81.12Risk vs reference allele
    LCE3D-LCE3Ers108885016.48Γ—10^-130.86Protective vs reference allele
    IL12Brs14732475.63Γ—10^-110.88Protective vs reference allele
    IL12Brs100767824.11Γ—10^-110.88Protective vs reference allele
    NFKBIArs128844681.05Γ—10^-80.88Protective vs reference allele

    Note: this table is restricted to SNPs explicitly shown in the provided extracted list, not the entire set of 15 new loci.

    BGPT next-step: If you want, I can generate a full locus-by-locus table (all 15 new loci + 4 replicated loci) only if the corresponding SNP-by-P/OR values are provided. With current input, only a partial set can be tabulated/visualized without guessing.

    Author reviews (open in BGPT)



    Feedback:    

    Updated: April 01, 2026

     BGPT Paper Review



    Study Novelty

    90%

    A large-scale whole-exome SNP-array GWAS with multi-stage replication that reports multiple additional coding loci is a high novelty increment relative to prior psoriasis GWAS focus, especially in the context of missing heritability and coding-variant coverage.



    Scientific Quality

    80%

    Quality is solid for statistical association mapping (QC, PCA, logistic regression, conditional/LD, and independent replication genotyping), but mechanistic support in the provided content is mostly in-silico/structure-inspection rather than extensive functional validation per variant.



    Study Generality

    70%

    Findings generalize best as adding plausible pathways/loci for psoriasis genetics; however, the primary discovery is in Han Chinese and array-based tagging/LD makes cross-ancestry generalization non-trivial.



    Study Usefulness

    70%

    Useful for prioritizing candidate coding/intronic loci and genes, especially those involving innate immunity/inflammasome-interferon/calcium/TGF-Ξ²-related pathways; less useful for immediate causal mechanism or predictive clinical risk without further validation.



    Study Reproducibility

    70%

    Reproducibility is moderate: methods and QC strategy are described, and variant data are reportedly deposited in dbVar; full reproducibility depends on access to the complete supplementary tables and the deposited variant-level dataset.



    Explanatory Depth

    60%

    Explanatory depth is intermediate: the paper provides pathway plausibility and some structure-based reasoning for AIM2, but does not (in the provided content) deliver variant-specific experimental mechanistic proof across the 15 new loci.


    🎁 Authors: Collect 296 Free Science Tokens (β‰ˆ $29.6 USD)

    Claim My Author Tokens

    Use for 74 days of free BGPT access (4 tokens = 1 day) or trade/sell (β‰ˆ $29.6 USD)

     Top Data Sources ExportMCP



     Analysis Wizard



    Compute per-SNP βˆ’log10(P) and OR-direction, then render a locus-by-gene summary table from the provided extracted rsIDs (MTHFR, IL1RL1, ZNF143, ZNF683, TMC6, LCE3D-LCE3E, IL12B, NFKBIA).



     Hypothesis Graveyard



    β€œAll 15 loci directly act through a single pathway” is weakened because the paper reports diverse genes/loci (methylenetetrahydrofolate metabolism, zinc fingers, calcium sensing, interferon receptor, inflammasome receptor), implying multi-pathway architecture.


    β€œProtective alleles are irrelevant to disease biology” is unlikely because OR<1 loci still show significant association and are used for pathway hypotheses; direction alone does not establish mechanism.

     Science Art


    Paper Review: Whole-exome SNP array identifies 15 new susceptibility loci for psoriasis Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT